 And maybe I'll first turn to you, Lionel, because Africa has obviously come as one of the regions that, despite its diversity, really came together in an amazing way in response to the pandemic. And could you elaborate on that and share a few thoughts on whether global governance will be regional governance, still has to be global in the future and could be about health, but why not about all other issues that we deal with here at the WPC? Thank you, Mr. President. You allowed me to speak in French. Of course, yes. Thank you. So, in fact, you asked me to double myself and not be myself in this panel. And you were absolutely right, because one of my colleagues who was very attached to being present today, Michel Sidibé, former Minister of Health, of the Republic of Mali, but above all, very remarkable, responsible patron of Onucida, couldn't be here physically, but wanted to be here intellectually. So he asked me to share a few messages that are exactly the same as what our excellent colleague just said. The African Union has been completely different in 2020-2021 from what we could think of and what it had been before and is a pretty remarkable example of a quick and promising response. So Michel Sidibé asks me to tell you that the situation is very worrying, in the sense that we are absolutely not ready for the developments, and at the same time, quite promising, in the sense that there has been a lot of innovation, especially governance in the current period, which has been prevailing for three years. He asks me to draw your attention on a certain number of symbolic figures, but still quite clear. Africa is nothing in terms of production, distribution, administration, access to medicine, treatment and equipment. That's a lot. Even if the use of vaccines in Africa has become important, 1% of these vaccines are produced by Africa itself. Even if there is an important development of treatment and medical consumption, 95% of medical consumption is imported to the African continent. That's obviously a record. On the other hand, where there are subjects close to the organized crime, according to the WHO, 40% of the volume of fake medicine in the world concerns the African continent. And we clearly have a public health system, but it is not just the administration of care, which is prevention, which is pharmaceutical distribution, access to medicine, which is equipment, which is and remains deeply defective. To give you an idea, the global pharmaceutical market in Michel's figures is the order of 1.4 trillion dollars, 1,400 billion dollars. The medical market, the pharmaceutical industry in Africa, is a little lower than 1 billion dollars. We are very below 1,000,000 for a continent that still looks like 18% of the world's population. So we are really in front of figures that indicate an extremely worrying situation. And yet, what are the primary elements? They are precisely the vision of governance. It is true that we were lucky to have in 2020 as the president of the African Union the president of the country the most advanced, whatever the parameters, in terms of equipment, access to care, laboratory, pharmaceutical distribution. And it is true that regardless of the governance of public health, and therefore a quick answer, there was also in the field of debt, there was also in the field of economic consequences of the pandemic, also quick and effective answers. Michel Sidibe is in charge of creating the African Medicines Agency which is going to be a very important progress. Today, on 55 member countries of the African Union, two are considered as having national medical agencies that are of international level. There is a class of the EMS, two, that of Egypt, that of the South African Republic, are at the top of the qualifications. It leaves 53 countries that are beyond that level. To create this agency, and it is a special envoy of the African Union to create it, is very significant. It will be in Kigali with an important political support. It will be a way to extend all that has been said of the CDC which has been saluted, I believe by you, which has been saluted in the previous panel as being an institution that has allowed to harmonize a lot of things in Africa very, very quickly during the pandemic in 2020. It will also be in the sense of digital platforms that have been put to the point extraordinarily quickly with the private sector, to the initiative of the African Union, and which have allowed to import all that could be imported at very low prices because it was digital platforms that allowed to have a complete vision of prices by franchising public markets and by using continental markets and not markets per country, and by having an automatic payment mechanism financed by Afreex in Banque, that is to say an incredible efficiency device. Incredible efficiency, except that what was incredible was that it did not, in many areas, especially vaccination, have available offers. It was different for the equipment, the respirators, the masks, etc. But for the vaccines, we had something that, I imagine, was the object of the pandemic that had an incredible protectionism and Africa was the victim of non-access to the vaccine. But from the point of view of governance and efficiency, we had a very complete response and extremely fast, because it was operational at the autumn of 2020. I have nothing to add to these two points. It is very worrying, but it is promising in terms of institutions and more than an act-based institution. If it is that I think we have to emphasize that the private sector, you mentioned the idea that there would be co-production of governance with the private sector, where the sector is associated with the big foundations, where the capacity to react to the global fund that has inscribed Covid very, very quickly in its priorities next to the other major pandemics, it is also a very important sector. And just a testimony as a banker today, obviously there is an important fund mobilization and the private sector reacts with very significant investment perspectives in all the health care compartments of public health and obviously on vaccines. But here again, we are working, for example, with the Bill and Melinda Gates Foundation, because we need funds for financing, for seed money, and with the Gates Foundation, we are deploying them to create a fabric of PME, because there are a lot of PME, clinics and pharmacy suppliers. There are, in the private sector, a lot of resources, except for financial resources, except for capital resources, and today it is an important share of financial development. The private sector exists. Thank you. Thank you very much. I would like to say here that evaluations of both the financial panel of the G20 and our independent panel are that for the preparation for the pandemic, the needs would be of the order of 15 billion per year, with the possibility also of having a kind of immediately mobilizable reserve of 50 to 100 billion, I will not go into the details, but these sums are obviously, as you have underlined, Mr. Zinzou, without comparison with the 22 billion of billion, estimated for the pandemic in the years 2020-2025.